Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea · Delayed Price · Currency is KRW 5,670.00
-130.00 (-2.24%)
At close: Jan 9, 2026
Kyongbo Pharmaceutical Market Cap
Kyongbo Pharmaceutical has a market cap or net worth of 135.55 billion as of January 9, 2026. Its market cap has decreased by -21.36% in one year.
Market Cap
135.55B
Enterprise Value
255.03B
Revenue
252.20B
Ranking
n/a
PE Ratio
57.35
Stock Price
5,670.00
Market Cap Chart
Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 135.55B, a decrease of -83.45%. That is a compound annual growth rate of -15.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 135.55B | -1.73% |
| Dec 30, 2025 | 137.94B | -7.23% |
| Dec 30, 2024 | 148.70B | -25.86% |
| Dec 28, 2023 | 200.58B | -16.10% |
| Dec 29, 2022 | 239.07B | -6.98% |
| Dec 30, 2021 | 257.00B | -34.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.80T |
| Celltrion | 46.17T |
| ALTEOGEN | 25.19T |
| ABL Bio | 11.60T |
| SK Biopharmaceuticals | 9.76T |
| Yuhan | 8.45T |
| HLB Co., Ltd. | 7.15T |
| LigaChem Biosciences | 6.51T |